HIGHLIGHTS
- who: Christopher J. Fay and colleagues from the Zhejiang University, China have published the paper: Harnessing the immune system in the treatment of cutaneous T cell lymphomas, in the Journal: (JOURNAL)
- what: The authors aim to provide a comprehensive and updated review of the immune modulating effects of all classes of therapeutics used and under development for CTCL . The authors report on the broadly accepted mechanism of action for each drug and Frontiers in Oncology 2 Biologic response modifiers
- future: Several retrospective and some prospective cohort studies have suggested that combination of interferon . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.